[ARS] Celularity Inc SEC Filing

Filing Impact

(Low)

Filing Sentiment

(Neutral)

Form Type

ARS

Rhea-AI Filing Summary

Analyzing...

11/07/2025 - 01:19 PM

ARS - Celularity Inc

ARS Filing - Celularity Inc

This filing is available as a PDF document.

Filing Type: ARS

Company: Celularity Inc (CELU)

Acceptance Date: 2025-11-07T13:19:07.000Z

View PDF Document

Source: View Original Filing on SEC EDGAR

Celularity Inc

NASDAQ:CELU

CELU Rankings

#5710 Ranked by Market Cap

N/A Ranked by Dividends

CELU Latest News

Dec 26, 2025

Celularity CEO Comments on Centers for Medicare & Medicaid Services’ Withdrawal of Skin Substitute Local Coverage Determinations

Dec 22, 2025

Celularity Announces Closing of Financing Transactions

Dec 18, 2025

Celularity Reaches Binding Term Sheets on Financing Transactions to Support Its Strategic Vision

Oct 30, 2025

Celularity and DefEYE, Inc. Partner to Advance Growth of Regenerative Therapies in Eye Care

Oct 14, 2025

Celularity Announces Peer-Reviewed Publication of Phase 2 Clinical Trial Results Demonstrating the Safety and Efficacy of Human Placenta-Derived Cells (PDA-002) for Diabetic Foot Ulcers Complicated by Peripheral Artery Disease

CELU Latest SEC Filings

Nov 21, 2025

[Form 4] Celularity Inc Insider Trading Activity

Nov 21, 2025

[Form 4] Celularity Inc Insider Trading Activity

Nov 21, 2025

[Form 4] Celularity Inc Insider Trading Activity

Nov 21, 2025

[Form 4] Celularity Inc Insider Trading Activity

Nov 14, 2025

[10-Q] Celularity Inc Quarterly Earnings Report

CELU Stock Data

Market Cap 38.35M

Float 16.54M

Insiders Ownership 50.57%

Institutions Ownership 13.14%

Short Percent 6.33%

Industry Biotechnology

Sector Pharmaceutical Preparations

Website Link

Country United States

City FLORHAM PARK